{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:55:03Z","timestamp":1771952103519,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer New York","isbn-type":[{"value":"9781493974979","type":"print"},{"value":"9781493974986","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7498-6_3","type":"book-chapter","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T12:14:30Z","timestamp":1512130470000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia"],"prefix":"10.1007","author":[{"given":"Kirsten","family":"Palmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"issue":"7","key":"3_CR1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, KF Y, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672\u2013683. \nhttps:\/\/doi.org\/10.1056\/NEJMoa031884","journal-title":"N Engl J Med"},{"issue":"4","key":"3_CR2","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajog.2005.10.192","volume":"194","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Qian C, Maynard SE, KF Y, Epstein FH, Karumanchi SA (2006) Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 194(4):1034\u20131041. \nhttps:\/\/doi.org\/10.1016\/j.ajog.2005.10.192","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"3_CR3","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2004-1955","volume":"90","author":"E Shibata","year":"2005","unstructured":"Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA (2005) Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90(8):4895\u20134903. \nhttps:\/\/doi.org\/10.1210\/jc.2004-1955","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3_CR4","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","volume":"59","author":"DE Clark","year":"1998","unstructured":"Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS (1998) A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59(6):1540\u20131548","journal-title":"Biol Reprod"},{"issue":"5","key":"3_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"S Maynard","year":"2003","unstructured":"Maynard S, Min J, Merchan J, Lim K, Li J, Mondal S, Libermann T, Morgan J, Sellke F, Stillman I, Epstein F, Sukhatme V, Ananth Karumanchi S (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649\u2013658","journal-title":"J Clin Invest"},{"issue":"11","key":"3_CR6","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1074\/jbc.M313237200","volume":"279","author":"HW Christinger","year":"2004","unstructured":"Christinger HW, Fuh G, de Vos AM, Wiesmann C (2004) The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J Biol Chem 279(11):10382\u201310388. \nhttps:\/\/doi.org\/10.1074\/jbc.M313237200","journal-title":"J Biol Chem"},{"issue":"5","key":"3_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0092-8674(00)80456-0","volume":"91","author":"C Wiesmann","year":"1997","unstructured":"Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM (1997) Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91(5):695\u2013704","journal-title":"Cell"},{"issue":"9","key":"3_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","volume":"95","author":"SAA Ahmad","year":"2004","unstructured":"Ahmad SAA (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95(9):884\u2013891. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000147365.86159.f5","journal-title":"Circ Res"},{"issue":"6","key":"3_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","volume":"50","author":"JS Gilbert","year":"2007","unstructured":"Gilbert JS, Babcock SA, Granger JP (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50(6):1142\u20131147. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.096594","journal-title":"Hypertension"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1073\/pnas.1011293108","volume":"108","author":"K Kumasawa","year":"2011","unstructured":"Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, Takakura N, Kimura T, Okabe M (2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A 108:1451. \nhttps:\/\/doi.org\/10.1073\/pnas.1011293108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6B","key":"3_CR11","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","volume":"14","author":"A Bergmann","year":"2010","unstructured":"Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, Christofori G, Gross V, Gonzalves A, Grone HJ, Ahmed A, Weich HA (2010) Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med 14(6B):1857\u20131867. \nhttps:\/\/doi.org\/10.1111\/j.1582-4934.2009.00820.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/HYPERTENSIONAHA.109.141937","volume":"55","author":"JS Gilbert","year":"2010","unstructured":"Gilbert JS, Verzwyvelt J, Colson D, Arany M, Karumanchi SA, Granger JP (2010) Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension 55(2):380\u2013385. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.141937","journal-title":"Hypertension"},{"issue":"4","key":"3_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","volume":"50","author":"Z Li","year":"2007","unstructured":"Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, O\u2019Young G, Sannajust F, Stathis P, Schreiner G, Karumanchi SA, Protter AA, Pollitt NS (2007) Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50(4):686\u2013692. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.092098","journal-title":"Hypertension"},{"issue":"3","key":"3_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.2015020157","volume":"27","author":"R Thadhani","year":"2016","unstructured":"Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T (2016) Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27(3):903\u2013913. \nhttps:\/\/doi.org\/10.1681\/ASN.2015020157","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/mend.13.4.0265","volume":"13","author":"Y He","year":"1999","unstructured":"He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS (1999) Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13(4):537\u2013545. \nhttps:\/\/doi.org\/10.1210\/mend.13.4.0265","journal-title":"Mol Endocrinol"},{"issue":"6","key":"3_CR16","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-08-2905","volume":"69","author":"N Rahimi","year":"2009","unstructured":"Rahimi N, Golde TE, Meyer RD (2009) Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1\/FLT1 in leukemic cancer cells. Cancer Res 69(6):2607\u20132614. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2905","journal-title":"Cancer Res"},{"issue":"3","key":"3_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.placenta.2008.12.010","volume":"30","author":"M Heydarian","year":"2009","unstructured":"Heydarian M, McCaffrey T, Florea L, Yang Z, Ross MM, Zhou W, Maynard SE (2009) Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 30(3):250\u2013255. \nhttps:\/\/doi.org\/10.1016\/j.placenta.2008.12.010","journal-title":"Placenta"},{"issue":"12","key":"3_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1161\/circresaha.108.171504","volume":"102","author":"S Sela","year":"2008","unstructured":"Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, Yagel S, Keshet E (2008) A novel human-specific soluble vascular endothelial growth factor receptor 1: cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res 102(12):1566\u20131574. \nhttps:\/\/doi.org\/10.1161\/circresaha.108.171504","journal-title":"Circ Res"},{"issue":"7","key":"3_CR19","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1210\/jc.2009-0017","volume":"94","author":"CP Thomas","year":"2009","unstructured":"Thomas CP, Andrews JI, Raikwar NS, Kelley EA, Herse F, Dechend R, Golos TG, Liu KZ (2009) A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab 94(7):2524\u20132530. \nhttps:\/\/doi.org\/10.1210\/jc.2009-0017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","volume":"58","author":"J Jebbink","year":"2011","unstructured":"Jebbink J, Keijser R, Veenboer G, van der Post J, Ris-Stalpers C, Afink G (2011) Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth. Hypertension 58(1):70\u201376. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.164079","journal-title":"Hypertension"},{"issue":"10","key":"3_CR21","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","volume":"118","author":"CL Whitehead","year":"2011","unstructured":"Whitehead CL, Palmer KR, Nilsson U, Gao Y, Saglam B, Lappas M, Tong S (2011) Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia. BJOG 118(10):1268\u20131271. \nhttps:\/\/doi.org\/10.1111\/j.1471-0528.2011.02962.x","journal-title":"BJOG"},{"issue":"6","key":"3_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","volume":"66","author":"KR Palmer","year":"2015","unstructured":"Palmer KR, Kaitu\u2019u-Lino TJ, Hastie R, Hannan NJ, Ye L, Binder N, Cannon P, Tuohey L, Johns TG, Shub A, Tong S (2015) Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity. Hypertension 66(6):1251\u20131259. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05883","journal-title":"Hypertension"},{"issue":"6","key":"3_CR23","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.3390\/ijms160612436","volume":"16","author":"CA Souders","year":"2015","unstructured":"Souders CA, Maynard SE, Yan J, Wang Y, Boatright NK, Sedan J, Balyozian D, Cheslock PS, Molrine DC, Simas TA (2015) Circulating levels of sFlt1 splice variants as predictive markers for the development of preeclampsia. Int J Mol Sci 16(6):12436\u201312453. \nhttps:\/\/doi.org\/10.3390\/ijms160612436","journal-title":"Int J Mol Sci"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/14767058.2016.1182975","volume":"30","author":"KR Palmer","year":"2017","unstructured":"Palmer KR, Kaitu\u2019u-Lino TJ, Cannon P, Tuohey L, De Silva MS, Varas-Godoy M, Acuna S, Galaz J, Tong S, Illanes SE (2017) Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia. J Matern Fetal Neonatal Med 30:635\u2013639. \nhttps:\/\/doi.org\/10.1080\/14767058.2016.1182975","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Methods in Molecular Biology","Preeclampsia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7498-6_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T10:04:46Z","timestamp":1524823486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7498-6_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"ISBN":["9781493974979","9781493974986"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7498-6_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]}}}